• Info
  • Insider Trading

Insider Transactions Reported by 14 Insiders of Trillium Therapeutics Inc.

Location
Mississauga, Ontario, Canada

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Trillium Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paolo Pucci Director 17 Nov 2021
Scott Dunseth Myers Director 17 Nov 2021
Paul Edward Walker Director 17 Nov 2021
LUKE M. BESHAR Director 17 Nov 2021
Parsons James T. Chief Financial Officer 17 Nov 2021
Michael E. Kamarck Director 17 Nov 2021
Robert Uger Chief Scientific Officer 17 Nov 2021
Rosemary Harrison Title: Senior Vice President, Corporate Development and Strategy 17 Nov 2021
Jan Skvarka President and CEO, Director 17 Nov 2021
Helen Tayton-Martin Director 17 Nov 2021
Penka Petrova Chief Development Officer 17 Nov 2021
Ingmar Bruns Chief Medical Officer 17 Nov 2021
CATHERINE J. MACKEY Director 17 Nov 2021
Benjamin Looker General Counsel 17 Nov 2021

Recent Insider Transactions by Companies or Individuals for Trillium Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Rosemary Harrison Common Shares Disposed to Issuer -100% -75 0 17 Nov 2021 Direct
Rosemary Harrison Stock Option (Right to Buy) Disposed to Issuer -100% -180,000 0 17 Nov 2021 Direct
Parsons James T. Stock Option (Right to Buy) Disposed to Issuer -100% -461,385 0 17 Nov 2021 Direct
Benjamin Looker Stock Option (Right to Buy) Disposed to Issuer -100% -190,000 0 17 Nov 2021 Direct
CATHERINE J. MACKEY Stock Option (Right to Buy) Disposed to Issuer -100% -67,000 0 17 Nov 2021 Direct
Ingmar Bruns Stock Option (Right to Buy) Disposed to Issuer -100% -400,000 0 17 Nov 2021 Direct
Penka Petrova Stock Option (Right to Buy) Disposed to Issuer -100% -316,822 0 17 Nov 2021 Direct
Robert Uger Stock Option (Right to Buy) Disposed to Issuer -100% -468,222 0 17 Nov 2021 Direct
KATRINA TAYTON MARTIN Stock Option (Right to Buy) Disposed to Issuer -100% -40,000 0 17 Nov 2021 Direct
KATRINA TAYTON MARTIN Deferred Share Unit Disposed to Issuer -100% -498,294 0 17 Nov 2021 Direct
Jan Skvarka Stock Option (Right to Buy) Disposed to Issuer -100% -1,959,500 0 17 Nov 2021 Direct
Paul Edward Walker Common Shares Disposed to Issuer -100% -5,736,363 0 17 Nov 2021 See Note 2
Paul Edward Walker Series II Non-Voting Convertible First Preferred Shares Disposed to Issuer -100% -6,750,000 0 17 Nov 2021 See Note 2
Paul Edward Walker Warrant to Purchase Common Shares Disposed to Issuer -100% -850,000 0 17 Nov 2021 See Note 2
Paul Edward Walker Warrant to Purchase Series II Preferred Shares Disposed to Issuer -100% -5,400,000 0 17 Nov 2021 See Note 2
Paul Edward Walker Stock Option (Right to Buy) Disposed to Issuer -100% -40,000 0 17 Nov 2021 Direct
Michael E. Kamarck Stock Option (Right to Buy) Disposed to Issuer -100% -67,000 0 17 Nov 2021 Direct
Paolo Pucci Stock Option (Right to Buy) Disposed to Issuer -100% -67,000 0 17 Nov 2021 Direct
Scott Dunseth Myers Stock Option (Right to Buy) Disposed to Issuer -100% -67,000 0 17 Nov 2021 Direct
LUKE M. BESHAR Stock Option (Right to Buy) Disposed to Issuer -100% -46,666 0 17 Nov 2021 Direct
LUKE M. BESHAR Deferred Share Unit Disposed to Issuer -100% -547,656 0 17 Nov 2021 Direct
Robert Uger Common Shares Options Exercise 3,646 3,646 07 Jul 2021 Direct
Robert Uger Common Shares Sale -100% -3,646 0 07 Jul 2021 Direct
Robert Uger Stock Option (Right to Buy) Options Exercise -3.45% -3,646 102,083 07 Jul 2021 Direct
CATHERINE J. MACKEY Stock Option (Right to Buy) Award 67,000 67,000 01 Jul 2021 Direct
Robert Uger Common Shares Options Exercise 3,646 3,646 07 Jun 2021 Direct
Robert Uger Common Shares Sale -100% -3,646 0 07 Jun 2021 Direct
Robert Uger Stock Option (Right to Buy) Options Exercise -3.33% -3,646 105,729 07 Jun 2021 Direct
Jan Skvarka Common Shares Options Exercise 23,802 23,802 12 May 2021 Direct
Jan Skvarka Common Shares Sale -100% -23,802 0 12 May 2021 Direct
Jan Skvarka Stock Option (Right to Buy) Options Exercise -10.8% -23,802 197,000 12 May 2021 Direct
Jan Skvarka Common Shares Options Exercise 106,698 106,698 11 May 2021 Direct
Jan Skvarka Common Shares Sale -100% -106,698 0 11 May 2021 Direct
Jan Skvarka Stock Option (Right to Buy) Options Exercise -32.6% -106,698 220,802 11 May 2021 Direct
Robert Uger Common Shares Options Exercise 3,646 3,646 07 May 2021 Direct
Robert Uger Common Shares Sale -100% -3,646 0 07 May 2021 Direct
Robert Uger Stock Option (Right to Buy) Options Exercise -3.23% -3,646 109,375 07 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.